0.0434  -0.018 (-29.77%)		06-05 16:00
Open: 0.05 High: 0.056 Volume: 50,913,348		Pre. Close: 0.0618 Low: 0.0434 Market Cap: 7(M)

Short term
Mid term
Targets	6-month :		1-year :
Resists	First :		Second :
Pivot price
Supports	First :		Second :
MAs	MA(5) :		MA(20) :
	MA(100) :		MA(250) :
MACD	MACD :		Signal :
%K %D	K(14,3) :		D(3) :
RSI	RSI(14):
52-week	High :		Low :

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

Cue Health Inc. is a healthcare technology firm dedicated to engineering and deploying advanced diagnostic platforms. These platforms facilitate various diagnostic tests, serving a broad spectrum of clients including individuals, enterprises, healthcare providers, payors, and public health agencies. Central to their offerings is the Cue Integrated Care platform, a comprehensive solution combining both physical hardware and sophisticated software. This platform encompasses the Cue Health Monitoring System, which features the portable, reusable Cue Reader, along with single-use Cue Cartridges and Cue Wands for sample collection. Digitally, it is supported by the Cue Data and Innovation Layer, offering robust cloud-based data and analytics capabilities, and the Cue Virtual Care Delivery Apps, including the consumer-focused Cue Health App and the business-oriented Cue Enterprise Dashboard. Additionally, the Cue Ecosystem Integrations and Apps provide seamless connectivity for third-party applications and sensors. The company also supplies specialized COVID-19 testing kits designed for use with its proprietary monitoring system. Established in 2010 and headquartered in San Diego, California, the organization originally operated as Cue Inc. before rebranding to Cue Health Inc. in December 2017.

Thu, 24 Apr 2025
Cue Health (HLTH) Stock Price, News & Analysis - Stock Titan

Tue, 28 May 2024
Cue Health files for Chapter 7 bankruptcy - Investing.com

Fri, 15 Dec 2023
Cue Health Inc.(NasdaqCM: HLTH) dropped from NASDAQ Biotechnology Index - marketscreener.com

Thu, 03 Aug 2023
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use - Business Wire

Mon, 08 May 2023
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home - Business Wire

Tue, 27 Sep 2022
Cue Health Appoints Suzanne Stone as New Chief Commercial Officer - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	(%)
Held by Institutions	(%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS
EPS Est Next Qtrly
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin	%
Operating Margin	%
Return on Assets (ttm)	%
Return on Equity (ttm)	%
Qtrly Rev. Growth	%
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth	%
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Dividend
Forward Dividend
Dividend Yield	0%
Dividend Pay Date
Ex-Dividend Date